Lynne M. Vickery‐Clark

A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670.

S A Douglas, Calvert Louden, Lynne M. Vickery‐Clark et al. · Circulation Research · 1994 · 199 citations · Full text

Medicine, Cardiology, Pharmacology +13

Expression of Endothelin-1, Endothelin-3, Endothelin-Converting Enzyme-1, and Endothelin-A and Endothelin-B Receptor mRNA After Angioplasty-Induced Neointimal Formation in the Rat

Xinkang Wang, Stephen A. Douglas, Calvert Louden et al. · Circulation Research · 1996 · 148 citations

Life Sciences, Molecular Biology, Physiology +9

Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways.

Douglas W.P. Hay, Roseanna M. Muccitelli, Stephanie S. Tucker et al. · PubMed · 1987 · 147 citations

Medicine, Pharmacology, Cell Signaling +12

Endothelin‐1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ‐123

Stephen A. Douglas, Lynne M. Vickery‐Clark, Eliot H. Ohlstein · British Journal of Pharmacology · 1993 · 50 citations · Full text

Life Sciences, Pharmacology, Physiology +15

Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat

SD Douglas, Lynne M. Vickery‐Clark, Calvert Louden et al. · Cardiovascular Research · 1995 · 46 citations

Medicine, Cardiology, Pharmacology +11